SCHEMBL29470189

SCHEMBL29470189

C[C@H](NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ OPRD1 P41143 5/20 0.46
▸ OPRM1 P35372 4/20 0.46
▸ OPRK1 P41145 1/20 0.46
▸ MME P08473 1/20 0.45
▸ ACE P12821 1/20 0.45
▸ CPA1 P15085 1/20 0.45
▸ ACE2 Q9BYF1 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1666819 0.94 MME (0.50) MME
SCHEMBL21794915 0.94 MME (0.50) MME
SCHEMBL1666817 0.94 MME (0.50) MME
Water SCHEMBL29655496 0.92 MME (0.49) MME
SCHEMBL30799848 0.92 OPRM1 (0.54) OPRD1OPRM1OPRK1MME
SCHEMBL29973895 0.91 PSMB1 (0.35) OPRD1OPRM1OPRK1
SCHEMBL29577210 0.90 MME (0.47) MME
SCHEMBL29511244 0.90 FNTA (0.47) MME
SCHEMBL30728889 0.90 MME (0.50) MME
SCHEMBL29531754 0.90 MME (0.50) MME

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12449422-B2 Method and composition matter for immunoproteasome-mediated delivery into living cells PURDUE RESEARCH FOUNDATION (US) 2025-10-21 — — US disclosed
US-20220120756-A1 METHOD AND COMPOSITION MATTER FOR IMMUNOPROTEASOME-MEDIATED DELIVERY INTO LIVING CELLS PURDUE RESEARCH FOUNDATION (US) 2022-04-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220120756-A1 METHOD AND COMPOSITION MATTER FOR IMMUNOPROTEASOME-MEDIATED DELIVERY INTO LIVING CELLS EXOSC5, PSMG3, EXOSC4 OPRD1 4556/4885OPRM1 4121/4885OPRK1 4357/4885
US-12449422-B2 Method and composition matter for immunoproteasome-mediated delivery into living cells EXOSC5, PSMG3, EXOSC4 OPRD1 4556/4885OPRM1 4121/4885OPRK1 4357/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback